Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04547673

To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
First Affiliated Hospital, Sun Yat-Sen University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Nasopharyngeal carcinoma (NPC) occurs at a high frequency in southern China, northern Africa, and Alaska, with a reported incidence of 30 cases per 100 000 in Guangdong Province. Endoscopic examination and biopsy are the main methods used for detection and diagnosis of NPC. Early NPC patients achieve favourable prognoses after concurrent radiotherapy and chemotherapy in compassion with advanced NPC patients. Here, the investigators focused on the utility of artificial intelligence to detect early NPC, which based on white light imaging (WLI) and Narrow-band imaging (NBI) nasoendoscopic examination. Having access to this unique population provides an unprecedented opportunity to investigate the effect of intelligent system on diverse nasopharyngeal lesions detection and develop a novel Computer-Aided Diagnosis System.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTrigid nasal endoscopesThe endoscope is introduced through the nasal passage to observe, in sequence, the posterior nostril, superior and posterior walls of the nasopharynx, torus tubarius, pharyngeal opening of the auditory tube, and Rosenmu¨ller recess. The imaging light mode is set to conventional WLI and subsequently switch to NBI during the procedure, and representative images are collected and preserve for further analysis. All lesions, detected by either WLI or NBI, are biopsied.

Timeline

Start date
2020-06-20
Primary completion
2024-10-31
Completion
2026-12-31
First posted
2020-09-14
Last updated
2024-02-20

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT04547673. Inclusion in this directory is not an endorsement.

To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma (NCT04547673) · Clinical Trials Directory